Skip to main content
Article thumbnail
Location of Repository

5-HT1A receptor activation improves anti-cataleptic effects of levodopa in 6-hydroxydopamine-lesioned rats

By J. Mahmoudi, A. Mohajjel Nayebi, M. Samini, S. Reyhani-Rad and V. Babapour
Topics: Original Article
Publisher: Tehran University of Medical Sciences
OAI identifier:
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    1. (1988). 5-Hydroxytryptamine1A receptors are linked to a Giadenylate cyclase complex in rat hippocampus.
    2. (2004). 8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodents.
    3. (2005). A serotonin 5HT1A receptor agonist prevents behavioral sensitization to L-DOPA in rodent model of Parkinson›s disease. Neuroscience Reaserch,
    4. (2008). Arterial baroreflex dysfunction fails to mimic Parkinson’s disease in rats.
    5. (2010). Buspirone improves 6-hydroxydopamineinduced catalepsy through stimulation of 5-HT1A receptors in rats. Pharmacol Rep,
    6. (2010). Buspirone improves haloperidol-induced Parkinson disease in mice through 5-HT1A receptors.
    7. (2009). Co-administration of the partial dopamine D2 agonist terguride with L-DOPA attenuates L-DOPA-induced locomotor sensitization in hemiparkinsonian mice. Behav Brain Res,
    8. (2007). Dopamine released from 5-HT terminals is the causeof L-DOPA-induced dyskinesia in parkinsonian rats.
    9. Hypothesis: A promising effect of 5-HT1A receptor agonists in alleviating motor symptoms of Parkinson’s disease.
    10. (2003). Increase of the striatal serotonergic fibers after nigrostriatal dopaminergic denervation in adult rats.
    11. (2008). Involvement of the serotonin system in L-DOPAinduced dyskinesias. Parkinsonism Relat Disord,
    12. (2006). Post-versus presynaptic plasticity in L-DOPA-induced dyskinesia.
    13. (1999). R(+)-8-OH-DPAT, a serotonin1A receptor agonist, potentiated S(–)-sulpirideinduced dopamine release in rat medial prefrontal cortex and nucleus accumbens but not striatum. J Pharmacol Exp Ther,
    14. (2000). Regulation of extracellular concentrations of 5-hydroxytryptamine (5-HT) in mouse striatum by 5-HT1A and 5-HT1B receptors. J Pharmacol Exp Ther,
    15. (2010). Role of cortical and striatal 5-HT1A receptors in alleviating antipsychotic-induced extrapyramidal disorders. Prog Neuropsychopharmacol Biol Psychiatry,
    16. (2001). Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models. Neurology,
    17. Serotonin neuron transplants exacerbate L-DOPA Induced dyskinesias in a rat model of Parkinson’s disease.
    18. (2007). Serotonin Neuron Transplants Exacerbate L-DOPAInduced Dyskinesias in a Rat Model of Parkinson’s Disease.
    19. (2008). Serotonin-dopamine interaction in induction and maintenance of L-DOPA-induced dyskinesias. Prog Brain Res,
    20. (2004). Stoessl AJ. presynaptic mechanisms of motor fluctuations in Parkinson’s disease: a probabilistic model.
    21. (2007). The partial 5-HT1A agonist buspirone reduces the expression and development of L-DOPA-induced dyskinesia in rats and improves L-DOPA efficacy. Pharmacol Biochem Behav,
    22. (1982). The rat brain in stereotaxic coordinates.
    23. (2005). Time (min) E l a p s e d t i m e i n B a r t e s t

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.